drugset / Trial / NCT00750633

A Phase III Study of an Otic Formulation in Acute Otitis Externa

NCT00750633

Phase 3 Completed 990 enrolled Alcon Research
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine if an otic formulation is safe and effective for the treatment of acute otitis externa (AOE).

Timeline

Start
2008-06
Primary completion
2009-01
Completion
2009-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 4 unknown Other
Subject Moxidex Unknown 4 unknown Other
Comparator Moxifloxacin Small molecule 4 unknown Other

Indications